Status:
UNKNOWN
Musculoskeletal Pain in Long COVID
Lead Sponsor:
University of Leeds
Collaborating Sponsors:
Leeds Comunity Healthcare NHS Trust
Conditions:
COVID-19
Musculoskeletal Pain
Eligibility:
All Genders
18+ years
Brief Summary
Long COVID is a new disease, with musculoskeletal pain being one of the common presenting symptoms. This longitudinal study will explore the long COVID musculoskeletal pain aetiology, pathophysiology,...
Detailed Description
Long COVID is defined as signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than four weeks and are not explained by an alternative diagnosis. It ...
Eligibility Criteria
Inclusion
- Individuals who have tested positive for COVID-19 or self-reported symptoms of COVID-19 confirmed by an independent clinician.
- New onset musculoskeletal pain that develops during or following an infection consistent with COVID-19, continues for 4 weeks or more and is not explained by an alternative diagnosis.
- Age 18 years or older.
- Ability of participant to understand and the willingness to sign a written informed consent document.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Ability of participant to read and understand English.
Exclusion
- People with pre-covid chronic pain syndrome.
- Unable to provide informed consent.
- Specific exclusion for Electroencephalogram (EEG): Patients with history of epileptic seizures.
Key Trial Info
Start Date :
April 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05358119
Start Date
April 30 2022
End Date
December 31 2024
Last Update
May 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, England, United Kingdom, LS1 3EX
2
Leeds Community Healthcare NHS Trust
Leeds, England, United Kingdom, LS6 1PF